pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
axelopran
Opioid-Induced Constipation (OIC)
Mu-type opioid receptor
$TBPHTheravance Biopharma, Inc.
0 catalysts
Phase 3
axicabtagene ciloleucel
Yescarta (axicabtagene ciloleucel)
Diffuse Large B-Cell Lymphoma
B-lymphocyte antigen CD19
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 3
azamidugene autotemcel
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
← prev
page 157 of 231
next →
131
Pain89
Neurology1
Kyowa Kirin Co Ltd
0 catalysts
Marketed
azathioprine
Azasan (azathioprine)
Kidney Transplant Rejection
Salix Pharmaceuticals Ltd
0 catalysts
Marketed
azelaic acid
Azelex (azelaic acid)
Acne Vulgaris
Almirall SA
0 catalysts
Marketed
azelastine hydrochloride
Azelastine Hydrochloride Wallace (azelastine hydrochloride)
Allergic Rhinitis
Wallace Pharmaceuticals Inc
0 catalysts
Phase 3
azeliragon
Coronavirus Disease 2019 (COVID-19)
Advanced glycosylation end product-specific receptor
Cantex Pharmaceuticals Inc
0 catalysts
Phase 2
azenosertib
azenosertib [INN]
Endometrial Cancer
$ZNTLZentalis Pharmaceuticals, Inc.
0 catalysts
Phase 1
azercabtagene zapreleucel
Diffuse Large B-Cell Lymphoma
Imugene Ltd
0 catalysts
Phase 2
azerutamig
azerutamig [INN]
Esophageal Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 3
azetukalner
Partial Seizure
$XENEXenon Pharmaceuticals Inc.
0 catalysts
Marketed
azilsartan kamedoxomil
Edarbi (azilsartan kamedoxomil)
Hypertension
Azurity Pharmaceuticals Inc
0 catalysts
Marketed
azithromycin
Azasite (azithromycin)
Bacterial Conjunctivitis
Thea Pharma Inc
0 catalysts
Marketed
aztreonam lysine
Cayston (aztreonam lysine)
Cystic Fibrosis
$GILDGILEAD SCIENCES, INC.
0 catalysts
Marketed
bacillus calmette-guerin [strain Montreal] vaccine
Pacis
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Shire Pharmaceuticals Inc
0 catalysts
Marketed
bacillus calmette-guerin [strain Tice] vaccine
BCG Vaccine
Tuberculosis
Organon USA LLC
0 catalysts
Marketed
bacitracin
Bacitracin (bacitracin [INN])
Bacterial Conjunctivitis
Padagis LLC
0 catalysts
Phase 2
bafisontamab
Bile Duct Cancer (Cholangiocarcinoma)
Epidermal growth factor receptorHepatocyte growth factor receptor
EpimAb Biotherapeutics Inc
0 catalysts
Preclinical
balipodect
Epilepsy
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Marketed
baloxavir marboxil
Xofluza (baloxavir marboxil)
Unspecified Influenza Virus Infections
Polymerase acidic protein
$SGIOFSHIONOGI & CO LTD
0 catalysts
Marketed
balsalazide disodium
Balsalazide Disodium (balsalazide disodium)
Ulcerative Colitis
Carnegie Pharmaceuticals LLC
0 catalysts
Phase 2
balstilimab
Metastatic Colorectal Cancer
Programmed cell death protein 1
$AGENAGENUS INC
0 catalysts
Phase 3
baluretgene parvec
Retinitis Pigmentosa (Retinitis)
$OCGNOcugen, Inc.
0 catalysts
Marketed
baricitinib
Olumiant (baricitinib)
Alopecia Areata
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
Eli Lilly and Co
0 catalysts
Phase 3
barzolvolimab
Chronic Urticaria
$CLDXCelldex Therapeutics, Inc.
0 catalysts
Marketed
basiliximab
Simulect (basiliximab)
Kidney Transplant Rejection
$NVSNOVARTIS AG
0 catalysts
Phase 3
basimglurant
Trigeminal Neuralgia (Tic Douloureux)
Metabotropic glutamate receptor 5
Noema Pharma AG
0 catalysts
Phase 1
basroparib
basroparib [INN]
Colorectal Cancer
ST Pharm Co Ltd
0 catalysts
Phase 2
batoclimab
batoclimab [INN]
Graves Diseases
$IMVTImmunovant, Inc.
0 catalysts
pre_registration
baxdrostat
Resistant Hypertension
$AZNASTRAZENECA PLC
0 catalysts